News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hefei Life Science to Develop Micell Technologies' Stent in China


10/3/2013 10:18:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 3, 2013 -- Hefei Life Science will fund the China clinical development of a drug eluting stent produced by Micell Technologies, a North Carolina interventional cardiology device maker. Once the stent is approved by the CFDA, Micell will continue to manufacture the MiStent SES. Sinopharm will be responsible for distribution, and SinoMedCare of Shanghai will contribute marketing and sales support. The agreement includes annual purchase commitments after the product is approved for sale. Hefei Life Science was established to bring high-tech bio-pharmaceutical projects with good market prospects to Hefei Life Science Park. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES